MarketPeel
Insider Trading Intelligence
MM

Milos Miljkovic

RNAC
CHIEF MEDICAL OFFICER · CARTESIAN THERAPEUTICS, INC. · CIK 0002000282
FILING MIX · LIFETIME56%/44%
BUYS
10
SELLS
8
TOTAL VALUE
$1.14M
COMPANIES
1
ACTIVE SINCE
Nov 2023
HOLDINGS NOW
58,820
AVG SELL PX
$15.94
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 7 pending
Forward-return performance of every backtestable P/S trade by Milos Miljkovic, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+40.00%+3.85%-0.46%+4.31%+6.32%
14d5+0.00%+8.73%+0.80%+7.94%+5.79%
30d5+20.00%+7.08%+1.17%+5.91%+7.95%
60d5+20.00%+3.84%-2.12%+5.96%+7.63%
90d5+60.00%-11.96%-4.47%-7.49%-6.61%
180d5(1 pending)+100.00%-37.85%+2.74%-40.60%-40.69%
1y5(1 pending)+100.00%-58.27%+15.43%-73.70%-74.02%
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RNAC · 58,820 shares · as of Jan 6, 2026
0175,750351,500527,250703,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 10 buys / 8 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RNAC
CARTESIAN THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,573$6.82$24.4K58,820Jan 6, 2026Jan 8, 2026View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,00062,393Jan 2, 2026Jan 6, 2026View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
77,00077,000Jan 2, 2026Jan 6, 2026View →
RNAC
CARTESIAN THERAPEUTICS, INC.
SALE
Chief Medical Officer
948$16.83$16.0K35,393Jan 6, 2025Jan 7, 2025View →
RNAC
CARTESIAN THERAPEUTICS, INC.
SALE
Chief Medical Officer
932$16.72$15.6K36,341Jan 3, 2025Jan 7, 2025View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00037,273Jan 2, 2025Jan 6, 2025View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
56,00056,000Jan 2, 2025Jan 6, 2025View →
RNAC
CARTESIAN THERAPEUTICS, INC.
SALE
Chief Medical Officer
20,00030,528Nov 15, 2024Nov 18, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
20,000$3.23$64.6K38,273Nov 15, 2024Nov 18, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
SALE
Chief Medical Officer
20,000$17.14$342.9K18,273Nov 15, 2024Nov 18, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
SALE
Chief Medical Officer
35,00050,528Nov 14, 2024Nov 18, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
SALE
Chief Medical Officer
35,000$16.13$564.6K18,273Nov 14, 2024Nov 18, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
35,000$3.23$113.0K53,273Nov 14, 2024Nov 18, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
85,52885,528Apr 8, 2024Apr 10, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
SALE
Chief Medical Officer
2,565.8720Apr 8, 2024Apr 10, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
703,000703,000Jan 2, 2024Jan 4, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
548,200548,200Jan 2, 2024Jan 4, 2024View →
RNAC
CARTESIAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,565.8722,565.872Nov 13, 2023Nov 15, 2023View →
Other insiders · RNAC
Loading peer insiders…
About this filer
CIK 0002000282
ROLE
Chief Medical Officer
PRIMARY
RNAC
COMPANIES
1
ACTIVE SINCE
Nov 2023
MARKETPEEL · /INSIDER/0002000282DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback